Aspiration (sclerosing) therapy of ovarian endometriomas: possibilities, prospects, long-term outcomes

This paper evaluated the effectiveness and longer-term outcomes of ultrasound-guided aspiration (sclerosing) therapy for endometrioid ovarian cysts in 124 reproductive-age women, including cases with unilateral/bilateral disease and prior recurrence after cystectomy. All patients received dienogest plus ethinylestradiol after the procedure, and key reported outcomes were early and 12-month endometrioma recurrence rates (≤9.7% at 3 months; 38.7% by 12 months) and spontaneous pregnancy during 7–12 months (36.3%, with childbirth in all cases). The authors explicitly note that sclerotherapy was not used as monotherapy and that outcomes depend on the adequacy of postoperative hormonal treatment. This paper is centrally about endometriosis — specifically, it focuses on aspiration (sclerosing) therapy and long-term recurrence/pregnancy outcomes in ovarian endometriomas.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works